GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Lisheng Pharmaceutical Co Ltd (SZSE:002393) » Definitions » 5-Year EBITDA Growth Rate

Tianjin Lisheng Pharmaceutical Co (SZSE:002393) 5-Year EBITDA Growth Rate : 7.00% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Tianjin Lisheng Pharmaceutical Co 5-Year EBITDA Growth Rate?

Tianjin Lisheng Pharmaceutical Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.32.

During the past 12 months, Tianjin Lisheng Pharmaceutical Co's average EBITDA Per Share Growth Rate was -42.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 68.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Tianjin Lisheng Pharmaceutical Co was 68.90% per year. The lowest was -31.50% per year. And the median was 9.20% per year.


Competitive Comparison of Tianjin Lisheng Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Lisheng Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Lisheng Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Lisheng Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Tianjin Lisheng Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.



Tianjin Lisheng Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Tianjin Lisheng Pharmaceutical Co  (SZSE:002393) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Tianjin Lisheng Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Tianjin Lisheng Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Lisheng Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.491 Huanghe Street, Nankai, Tianjin, CHN, 300111
Tianjin Lisheng Pharmaceutical Co Ltd manufactures and sells tablet medicine, capsule medicine, pill, freeze-dry powder injection, liquid injection and raw material medicine.
Executives
Zhang Tong Sheng Director
Shi Xue Rong Supervisors
Zhao Yu Ming Director

Tianjin Lisheng Pharmaceutical Co Headlines

No Headlines